Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles Medical Center, Torrance, California, United States of America.
PLoS One. 2012;7(8):e43958. doi: 10.1371/journal.pone.0043958. Epub 2012 Aug 27.
The lipopeptide antibiotic, daptomycin (DAP) interacts with the bacterial cell membrane (CM). Development of DAP resistance during therapy in a clinical strain of Enterococcus faecalis was associated with mutations in genes encoding enzymes involved in cell envelope homeostasis and phospholipid metabolism. Here we characterized changes in CM phospholipid profiles associated with development of DAP resistance in clinical enterococcal strains.
Using two clinical strain-pairs of DAP-susceptible and DAP-resistant E. faecalis (S613 vs. R712) and E. faecium (S447 vs. R446) recovered before and after DAP therapy, we compared four distinct CM profiles: phospholipid content, fatty acid composition, membrane fluidity and capacity to be permeabilized and/or depolarized by DAP. Additionally, we characterized the cell envelope of the E. faecium strain-pair by transmission electron microscopy and determined the relative cell surface charge of both strain-pairs.
Both E. faecalis and E. faecium mainly contained four major CM PLs: phosphatidylglycerol (PG), cardiolipin, lysyl-phosphatidylglycerol (L-PG) and glycerolphospho-diglycodiacylglycerol (GP-DGDAG). In addition, E. faecalis CMs (but not E. faecium) also contained: i) phosphatidic acid; and ii) two other unknown species of amino-containing PLs. Development of DAP resistance in both enterococcal species was associated with a significant decrease in CM fluidity and PG content, with a concomitant increase in GP-DGDAG. The strain-pairs did not differ in their outer CM translocation (flipping) of amino-containing PLs. Fatty acid content did not change in the E. faecalis strain-pair, whereas a significant decrease in unsaturated fatty acids was observed in the DAP-resistant E. faecium isolate R446 (vs S447). Resistance to DAP in E. faecium was associated with distinct structural alterations of the cell envelope and cell wall thickening, as well as a decreased ability of DAP to depolarize and permeabilize the CM.
Distinct alterations in PL content and fatty acid composition are associated with development of enterococcal DAP resistance.
脂肽抗生素达托霉素(DAP)与细菌细胞膜(CM)相互作用。在临床粪肠球菌株的治疗过程中,DAP 耐药的发展与参与细胞包膜稳态和磷脂代谢的酶编码基因的突变有关。在这里,我们描述了与临床肠球菌株 DAP 耐药发展相关的 CM 磷脂谱的变化。
使用两株临床敏感和耐药的粪肠球菌(S613 对 R712)和屎肠球菌(S447 对 R446)的药敏试验前后的菌株对,我们比较了四种不同的 CM 谱:磷脂含量、脂肪酸组成、膜流动性以及被 DAP 渗透和/或去极化的能力。此外,我们通过透射电子显微镜对屎肠球菌株系的细胞包膜进行了特征描述,并确定了两株系的相对细胞表面电荷。
粪肠球菌和屎肠球菌的 CM 主要含有四种主要的 PL:磷脂酰甘油(PG)、心磷脂、赖氨酸磷脂酰甘油(L-PG)和甘油磷酸二甘油酰基甘油(GP-DGDAG)。此外,粪肠球菌的 CM 还含有:i)磷脂酸;和 ii)另外两种未知的含氨基 PL 物种。两种肠球菌耐药性的发展都与 CM 流动性和 PG 含量的显著降低有关,同时 GP-DGDAG 增加。这两个菌株对在外 CM 中氨基酸 PL 的转运(翻转)没有差异。粪肠球菌菌株对的脂肪酸含量没有变化,而 DAP 耐药的屎肠球菌分离株 R446 的不饱和脂肪酸含量显著降低(与 S447 相比)。屎肠球菌对 DAP 的耐药性与细胞包膜的结构改变和细胞壁增厚有关,以及 DAP 去极化和渗透 CM 的能力下降。
PL 含量和脂肪酸组成的明显改变与肠球菌 DAP 耐药的发展有关。